Medical therapy of peripheral arterial occlusive disease

J. P. Cooke; A. O. Ma

doi:10.1016/S0039-6109(16)46682-X

Medical therapy of peripheral arterial occlusive disease

J. P. Cooke, A. O. Ma

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Lowering the overall morbidity rate of peripheral vascular disease requires a systematic approach to the patient with atherosclerosis. This includes comprehensive assessments of risk factors, appropriate modifications of diet and lifestyle as well as an effective and sustaining exercise regimen. The role of new pharmacologic agents is discussed.

Original language	English (US)
Pages (from-to)	569-579
Number of pages	11
Journal	Surgical Clinics of North America
Volume	75
Issue number	4
DOIs	https://doi.org/10.1016/S0039-6109(16)46682-X
State	Published - 1995

ASJC Scopus subject areas

Surgery

Access to Document

10.1016/S0039-6109(16)46682-X

Cite this

@article{446d2bc823044343bff5508543ea11e1,

title = "Medical therapy of peripheral arterial occlusive disease",

abstract = "Lowering the overall morbidity rate of peripheral vascular disease requires a systematic approach to the patient with atherosclerosis. This includes comprehensive assessments of risk factors, appropriate modifications of diet and lifestyle as well as an effective and sustaining exercise regimen. The role of new pharmacologic agents is discussed.",

author = "Cooke, {J. P.} and Ma, {A. O.}",

note = "Funding Information: Suzanne Farrugia for typing the manuscript and Stephen Medcalf from The Royal North Shore Hospital, Sydney for supplying the control strain of B. fragilis ATCC 25285. This study was supported in part by Beecham Research Laboratories and Merck, Sharp and Dohme, Australia. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "1995",

doi = "10.1016/S0039-6109(16)46682-X",

language = "English (US)",

volume = "75",

pages = "569--579",

journal = "Surgical Clinics of North America",

issn = "0039-6109",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Medical therapy of peripheral arterial occlusive disease

AU - Cooke, J. P.

AU - Ma, A. O.

N1 - Funding Information: Suzanne Farrugia for typing the manuscript and Stephen Medcalf from The Royal North Shore Hospital, Sydney for supplying the control strain of B. fragilis ATCC 25285. This study was supported in part by Beecham Research Laboratories and Merck, Sharp and Dohme, Australia. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 1995

Y1 - 1995

N2 - Lowering the overall morbidity rate of peripheral vascular disease requires a systematic approach to the patient with atherosclerosis. This includes comprehensive assessments of risk factors, appropriate modifications of diet and lifestyle as well as an effective and sustaining exercise regimen. The role of new pharmacologic agents is discussed.

AB - Lowering the overall morbidity rate of peripheral vascular disease requires a systematic approach to the patient with atherosclerosis. This includes comprehensive assessments of risk factors, appropriate modifications of diet and lifestyle as well as an effective and sustaining exercise regimen. The role of new pharmacologic agents is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0029154740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029154740&partnerID=8YFLogxK

U2 - 10.1016/S0039-6109(16)46682-X

DO - 10.1016/S0039-6109(16)46682-X

M3 - Article

C2 - 7638705

AN - SCOPUS:0029154740

SN - 0039-6109

VL - 75

SP - 569

EP - 579

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

IS - 4

ER -

Medical therapy of peripheral arterial occlusive disease

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this